A composition for inhibiting an abnormal vasculogenesis, which comprises as active ingredient at least one compound selected from the group consisting of D-mannose and/or a derivative thereof, D-allose and/or a derivative thereof, 2-deoxy-D-glucose and/or a derivative thereof, 3-deoxy-D-glucose and/or a derivative thereof, L-sorbose and/or a derivative thereof, 2-deoxy-D-ribose and/or a derivative thereof, and 2-deoxy-L-ribose and/or a derivative thereof, and/or at least one compound selected from the group consisting of D-allose and/or a derivative thereof, D-altrose and/or a derivative thereof, D-gulose and/or a derivative thereof, D-talose and/or a derivative thereof, L-allose and/or a derivative thereof, 2-deoxy-D-glucose and/or a derivative thereof, 3-deoxy-D-glucose and/or a derivative thereof, D-ribose and/or a derivative thereof, L-ribose and/or a derivative thereof, 2-deoxy-D-ribose and/or a derivative thereof, and 2-deoxy-L-ribose and/or a derivative thereof.